Table 1.
Distribution of HLA-DQ genotypes in individuals with CeD in drug and placebo groups
| Drug (n = 34) | Placebo (n = 24) | |||
|---|---|---|---|---|
| n | % | n | % | |
| G1 | 6 | 17.6 | 2 | 8.3 |
| DQ2.5 homozygous | 5 | 14.7 | 1 | 4.2 |
| DQ2.5/DQ2.3 | 1 | 2.9 | 0 | 0.0 |
| DQ2.5/one copy of DQB1*02 | 0 | 0.0 | 1 | 4.2 |
| G2 | 14 | 41.2 | 6 | 25.0 |
| DQ2.2 homozygous | 4 | 11.8 | 2 | 8.3 |
| DQ8 homozygous | 6 | 17.6 | 1 | 4.2 |
| DQ8/DQ2 | 2 | 5.9 | 2 | 8.3 |
| DQ2.5/DQ2.2 | 2 | 5.9 | 1 | 4.2 |
| G3 | 14 | 41.2 | 15 | 62.5 |
| DQ2 half heterodimer | 8 | 23.5 | 6 | 25.0 |
| DQ2.2 heterozygous | 1 | 2.9 | 4 | 16.7 |
| DQ2.5 heterozygous | 4 | 11.8 | 3 | 12.5 |
| DQ8 heterozygous | 1 | 2.9 | 1 | 4.2 |
| DQ2.5/one copy of DQA1*05 | 0 | 0.0 | 1 | 4.2 |
| Not identified | 0 | 0.0 | 1 | 4.2 |